← Open Payments lookup

MATTHEW CONYERS: Open Payments

NPI 1992926422 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$675 in 31 payments from 13 companies in 2025. Trend: 2023 $634 · 2024 $337 · 2025 $675

Food & beverage: $675
CompanyPaymentsAmount
GlaxoSmithKline, LLC.10$231
Boehringer Ingelheim Pharmaceuticals, Inc.4$97
AstraZeneca Pharmaceuticals LP4$67
Lilly USA, LLC2$56
Insmed, Inc.2$48
Amgen Inc.2$33
Actelion Pharmaceuticals US, Inc.1$27
Phathom Pharmaceuticals, Inc.1$24
Novo Nordisk Inc1$21
Boston Scientific Corporation1$20

Products named: TRELEGY ELLIPTA, AIRSUPRA, KISUNLA, Arikayce, JARDIANCE, OTEZLA, OPSUMIT, VOQUEZNA.

Industry payments across FL — which companies pay providers there.